Artificial intelligence could have a huge impact on drug discovery.
Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?
Sitting Down With... Melissa Hanna-Brown, Analytical Technology & Innovation Lead, Pfizer Global R&D, Sandwich, UK.
It’s time for pharma to join the crowdsourcing revolution.
There is a shocking lack of attention given to racemization in drug discovery, despite it having huge implications on the efficacy – and safety – of drugs. We hope the tool we have developed will be the first step towards change.
A tool to predict racemization could help prevent drug discovery dead ends
Pan Pantziarka and Gauthier Bouche
New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.
Should we target minor rather than major infections with new therapeutics to best fight antibiotic resistance?
An analgesic is helping researchers explore new drug targets for sight-threatening diseases
The gates for gene and cell therapies are open, and RNAi technology could be a serious contender
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.